The Acute Coronary Syndrome Study (ACS)

December 4, 2009 updated by: Ullevaal University Hospital

The Acute Coronary Syndrome Study. Organization and Treatment of Patients With Acute Coronary Syndrome, With a Focus on Costs, Organization and Security

The investigators will make a prospective study in which they will look at the economics and security of the treatment of patients with acute coronary syndrome.

The investigators want to do a randomized trial. One group will be treated as they have been treated at Ullevål University Hospital (UUS) in recent years, and the other group will be returned to their refering hospital the same day. The objective of this study will be to provide increased knowledge about whether the rapid discharge from the intervention center is associated with differences in costs or security.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

The topic of this study is whether patients with Acute coronary syndrome (ACS)may can be transferred to their refering hospital same day that they arrived intervention hospital.

This is to see if one can reduce the hospital stay and costs for the intervention center, and the total hospitalization time.

and this rapid transport not give more medical complications

Our 1 hypothesis is that patients with ACS, who are transported back to the refering hospital the same day, will reduce the length of stay in intervention center without an increase for the stay at the refering hospital.

Our 2 hypothesis is that patients with ACS, who are transported back to the refering hospital the same day as the treatment is performed, have no more complications than those who stay overnight in the intervention hospital.

Study Type

Interventional

Enrollment (Anticipated)

400

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Norway
      • Oslo, Norway, 0407
        • Recruiting
        • Oslo University Hospital, Ullevaal
        • Contact:
          • Jack Gunnar Andersen, Master of Management
          • Phone Number: +47 98 64 16 34
          • Email: jaga@uus.no
        • Contact:
          • Odd Johansen, ph. d MD
          • Phone Number: +47 22 11 93 81
          • Email: odjo@uus.no
        • Principal Investigator:
          • Jack Gunnar Andersen, Master of Management

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • All patients with acute coronary syndrome who are referred from other hospitals

Exclusion Criteria:

  • Patients younger than 18years.
  • Known mental retardation, dementia or harmful use of alcohol or drugs.
  • Allergy or intolerance to ASA and / or clopidogrel.
  • Patients who have previously been involved in this study.
  • Acute STEMI infarction for less than 72 hours ago.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group 1 Fast Track Group
The patients are discharged the same day after coronary angiography to the refering Hospital
Other: Early discharge
The patients are discharged the same day as coronary angiography.
Active Comparator: Group 2: Ordinary care
Ordinary Cardiology care in the Intervention hospital
Other: Care as usual. No intervention. (Control group)
The patients are admitted and cared as usual in cardiology ward.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Cost effectiveness. Adverse medical events
Time Frame: 30 days and a year's events
30 days and a year's events

Secondary Outcome Measures

Outcome Measure
Time Frame
SF-36
Time Frame: One year
One year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Ullevaal University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2009

Primary Completion (Anticipated)

June 1, 2010

Study Completion (Anticipated)

May 1, 2013

Study Registration Dates

First Submitted

December 4, 2009

First Submitted That Met QC Criteria

December 4, 2009

First Posted (Estimate)

December 7, 2009

Study Record Updates

Last Update Posted (Estimate)

December 7, 2009

Last Update Submitted That Met QC Criteria

December 4, 2009

Last Verified

December 1, 2009

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • REK: 6.2008.1724

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Coronary Syndrome

Clinical Trials on Early discharge

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe